Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 753018100 since 12/18/2024, largest first.
| Filer | % of Class | Filed | ||
|---|---|---|---|---|
|
InCube Labs, L.L.C.
13D/A
|
22.1% |
10/27/2025
Event 10/23/2025
|
||
| InCube Labs, L.L.C. | 18.7% | |||
| Mir A Imran | 22.1% | |||
| InCube Ventures II, LP | 0.3% | |||
| Rani Investment Corp. | 0% | |||
|
Invus Global Management, LLC
13G
|
10.0% |
10/23/2025
Event 10/16/2025
|
||
| Invus Public Equities, L.P. | 8.8% | |||
| Invus Public Equities Advisors, LLC | 8.8% | |||
| Invus Global Management, LLC | 8.8% | |||
| Siren, L.L.C. | 8.8% | |||
| Avicenna Life Sci Master Fund LP | 1.3% | |||
| Avicenna Life Sci Master GP LLC | 1.3% | |||
| Ulys, L.L.C. | 1.3% | |||
| Raymond Debbane | 10.0% | |||
|
RA Capital Management, L.P.
13G/A
|
9.9% |
8/14/2026
Event 6/30/2026
|
||
| RA Capital Management, L.P. | 9.9% | |||
| Peter Kolchinsky | 9.9% | |||
| Rajeev Shah | 9.9% | |||
| RA Capital Healthcare Fund, L.P. | 9.9% | |||
|
Samsara BioCapital, L.P.
13D/A
|
9.9% |
5/28/2026
Event 5/26/2026
|
||
| Samsara BioCapital, L.P. | 5.0% | |||
| Samsara BioCapital GP, LLC | 5.0% | |||
| Samsara Opportunity Fund, L.P. | 5.0% | |||
| Samsara Opportunity Fund GP, LLC | 5.0% | |||
| Srinivas Akkaraju | 9.9% | |||
| AWM Investment Company, Inc. 13G | 9.9% |
2/13/2026
Event 12/31/2025
|
||
| Under 5%, checked the "5 percent or less" box, or amended by a later filing (5) | ||||
|
Armistice Capital, LLC
13G/A
Amended
under CUSIP
89455T109
on 11/14/2025
|
9.9% |
8/15/2025
Event 6/30/2025
|
||
| Armistice Capital, LLC | 9.9% | |||
| Steven Boyd | 9.9% | |||
|
South Cone Investments Limited Partnership
13D/A
|
4.9% |
10/22/2025
Event 10/20/2025
|
||
| South Cone Investments Limited Partnership | 4.9% | |||
| South Lake One LLC | 4.9% | |||
| South Lake Management LLC | 4.9% | |||
| Vanguard Capital Management LLC 13G/A | 4.5% |
7/31/2026
Event 6/30/2026
|
||
| Orca Capital AG 13G/A | 4.3% |
7/23/2025
Event 7/22/2025
|
||
| Vanguard Group Inc 13G/A | 0% |
3/27/2026
Event 3/13/2026
|
||
| Period | Filings | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q3 | 1 | 13.8 k | $10.9 k |
| 2026 Q2 | 71 | 45.7 M | $34.7 M |
| 2026 Q1 | 79 | 42.7 M | $31.4 M |
| 2025 Q4 | 71 | 44.8 M | $60.5 M |
| 2025 Q3 | 39 | 4.03 M | $2.02 M |
| 2025 Q2 | 43 | 6.46 M | $3.32 M |
| 2025 Q1 | 42 | 3.61 M | $4.58 M |
| 2024 Q4 | 47 | 3.82 M | $5.23 M |
| 2024 Q3 | 35 | 5.91 M | $12.8 M |
| 2024 Q2 | 42 | 3.11 M | $11.8 M |
| 2024 Q1 | 44 | 3.47 M | $10.8 M |
| 2023 Q4 | 37 | 3.30 M | $11.0 M |
| 2023 Q3 | 35 | 3.21 M | $6.96 M |
| 2023 Q2 | 38 | 3.23 M | $13.3 M |
| 2023 Q1 | 39 | 3.00 M | $15.5 M |
| 2022 Q4 | 36 | 2.98 M | $17.8 M |
| 2022 Q3 | 33 | 3.17 M | $30.4 M |
| 2022 Q2 | 29 | 2.83 M | $29.1 M |
| 2022 Q1 | 25 | 2.56 M | $34.5 M |
| 2021 Q4 | 23 | 1.24 M | $20.3 M |
| 2021 Q3 | 16 | 1.10 M | $19.6 M |